Skip to main content

fda_approval · bla · info

REGENERON PHARMACEUTICALS, INC — BLA approval: Unspecified (unspecified)

Event date
2026-08-19 00:00:00Z
Observed
2026-08-22 04:30:38Z
Source ID
BLA761508-1
Payload hash
e96cdf5d880ff206ee593625

Summary

REGENERON PHARMACEUTICALS, INC received BLA approval for Unspecified (unspecified) on 2026-08-19. Dosage form: unspecified dosage form. Application #: BLA761508.

Frequently asked questions

Has Regeneron Pharmaceuticals Inc had other FDA enforcement actions?
Yes. Argus HQ has recorded 4 total FDA actions tied to Regeneron Pharmaceuticals Inc: 0 warning letters, 3 recalls, 1 approval record, and 0 Form 483 inspection citations.
What kind of FDA record is this?
This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-08-19; Argus observed and indexed it on 2026-08-22.
Where can I verify this record directly with FDA?
The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA
Argus HQ Research (2026). REGENERON PHARMACEUTICALS, INC — BLA approval: Unspecified (unspecified). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-approval-regeneron-pharmaceuticals-inc-bla761508-1
MLA
"REGENERON PHARMACEUTICALS, INC — BLA approval: Unspecified (unspecified)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-approval-regeneron-pharmaceuticals-inc-bla761508-1.
Chicago
Argus HQ Research. "REGENERON PHARMACEUTICALS, INC — BLA approval: Unspecified (unspecified)." Digital Empire Holdings LLC. Accessed September 8, 2026. https://argushq.ai/events/fda-approval-regeneron-pharmaceuticals-inc-bla761508-1.
BibTeX
@misc{argushq_argushq_ai_events_fda_approval_regeneron_pharmaceuticals_inc_bla761508_1_2026,
  title = {REGENERON PHARMACEUTICALS, INC — BLA approval: Unspecified (unspecified)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-approval-regeneron-pharmaceuticals-inc-bla761508-1},
  note = {Accessed: September 8, 2026}
}

Informational only. Not legal, financial, or medical advice.

REGENERON PHARMACEUTICALS, INC — BLA approval: Unspecified (unspecified) · Argus HQ